TIDMAPH
RNS Number : 5585S
Alliance Pharma PLC
07 November 2023
For immediate release 7 November 2023
ALLIANCE PHARMA
("Alliance", "Company" or the "Group")
Appointment of Non-Executive Directors
Alliance Pharma plc (AIM: APH), the international healthcare
group, is pleased to announce the appointment of Eva-Lotta Sjöstedt
and Richard McKenzie as new independent Non-Executive Directors to
strengthen the Board and support the delivery of the Company's
growth strategy. Both Eva-Lotta and Richard will join the Board
with immediate effect.
Eva-Lotta Sjöstedt
Eva-Lotta has in-depth knowledge of global consumer retail,
supply chain and digital transformation and has held leadership
roles in consumer-facing industries across Europe, Japan, China and
the USA.
From 2016 to 2018, Eva-Lotta was CEO of Georg Jensen, the luxury
jewellery and Scandinavian design brand, where she led a global
team of 1,400 to implement an omni-channel turnaround in retail
networks. Prior to this Eva-Lotta was CEO at Karstadt, a chain of
premium department stores in Germany with a strong e-commerce
presence. She started her career at IKEA, establishing the business
in Japan where she worked for four years before becoming CEO of
IKEA Netherlands and then Deputy Global Retail Manager. In this
role she was responsible for IKEA's global multi-channel strategy
and the implementation of its on and offline experiences throughout
the entire global value chain.
Eva-Lotta is currently a NED at FTSE-250 listed Tritax Eurobox,
which operates, manages and invests in real estate assets across
Continental Europe. Eva-Lotta joined the Board of Tritax Eurobox in
2019 and she Chairs the ESG committee and sits on the Nomination
and Management Engagement committees. She is a member of the Board
of ELISA Oyj, a digital services and telecommunications company
listed on Nasdaq Helsinki, and is also a member of the Supervisory
Board of Metro AG, a German wholesale food specialist operating in
35 countries.
We believe that Eva-Lotta's experience will strengthen the
European dimension of the Alliance Board whilst providing valuable
e-commerce and multi-channel experience.
Richard McKenzie
Richard has international e-commerce, distribution, supply chain
and logistics experience in the consumer, retail and technology
sectors, along with particular expertise in the Asia-Pacific region
having lived and worked in mainland China for 10 years.
From 2019 to 2023, Richard was Chief Commercial Officer and
latterly President (Europe and Asia) for Ocado Solutions, driving
the growth of this leading grocery e-commerce platform globally.
During his tenure at Ocado Solutions, Richard led major new deals
with distributors in Korea, Japan, Spain and Poland, and redesigned
the B2B organisation of the business. Prior to this Richard was a
strategy consultant for OC&C in London and China, building the
company's presence in Asia-Pacific, before becoming a Senior
Partner for the Consumer Goods and Retail practice of Oliver Wyman
in Asia Pacific. During this time, he built extensive experience of
the retail consumer market in China, and Asia-Pacific more
broadly.
Richard is currently a Senior Advisor to McKinsey and
Company.
We believe that Alliance will benefit from Richard's significant
operational experience, particularly in the rapidly evolving
distribution channels and cross border e-commerce markets in China
and Asia-Pacific, whilst his career in consultancy will bring
additional strategic oversight.
Jo LeCouilliard, Chair of Alliance, said :
"I am delighted to welcome Eva-Lotta and Richard to the Board
and look forward to their contribution to support the delivery of
our growth strategy. Eva-Lotta will bring significant additional
global consumer expertise from her various senior executive
leadership roles, and Richard will bring significant additional
strategic and operational expertise, particularly in our important
China market."
The following information is disclosed pursuant to Schedule Two,
paragraph (g), of the AIM Rules for Companies.
Mrs Eva-Lotta Saga Sjöstedt, aged 56, has been a director of the
following companies during the five years preceding the date of
this announcement:
Current directorships Directorships in the past five
-- Metro AG years:
-- Tritax Eurobox PLC
-- Elisa Oyj None within past five years
-- Pigos Holding AB
-- Tultan AB
-- Kuno Leadership Community
AB
Mrs Eva-Lotta Sjöstedt does not hold any ordinary shares of 1
pence each in the Company.
Mr Richard Alexander McKenzie, aged 51, has been a director of
the following companies during the five years preceding the date of
this announcement:
Current directorships Directorships in the past five
-- Strategy Max Ltd years:
-- Karakuri Ltd*
-- Ocado Intelligent Automation None within past five years
Ltd
* Karakuri Ltd was placed into administration by its directors
on 28 July 2023. All substantive trade and employee liabilities
were settled in full, and shareholder loan notes were written
off.
Mr Richard McKenzie does not hold any ordinary shares of 1 pence
each in the Company.
For further information:
Alliance Pharma plc + 44 (0)1249 466966
Cora McCallum, Head of Investor Relations
& Corporate Communications + 44 (0)1249 705168
ir@allianceph.com
+ 44 (0)20 7466
Buchanan 5000
Mark Court / Sophie Wills
alliancepharma@buchanan.uk.com
Deutsche Numis (Nominated Adviser and Joint + 44 (0)20 7260
Broker) 1000
Freddie Barnfield / Duncan Monteith / Sher
Shah
+ 44 (0)20 7597
Investec Bank plc (Joint Broker) 5970
Corporate Broking: Patrick Robb / Maria
Gomez de Olea
About Alliance
Alliance Pharma plc (AIM: APH) is an international healthcare
group. Our purpose is to improve the lives of consumers and
patients through making available a range of clinically valuable
healthcare products.
Our core focus is on the marketing of Consumer Healthcare
brands, complemented by a smaller Prescription Medicines business.
In total, we hold marketing rights to around 80 brands, with
revenues generated from a mix of direct, distributor and e-commerce
sales.
Headquartered in the UK, the Group employs around 250 people
based in locations across Europe, North America, and the Asia
Pacific region. By outsourcing our manufacturing and logistics
operations, we remain asset-light and focused on maximising the
value of our brands.
For more information on Alliance, please visit our website :
www.alliancepharmaceuticals.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOAGZMGMLVNGFZM
(END) Dow Jones Newswires
November 07, 2023 02:00 ET (07:00 GMT)
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Apr 2023 to Apr 2024
